Page 4 - Robin Swartz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robin swartz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robin Swartz Today - Breaking & Trending Today

Voyager Therapeutics, Inc. (NASDAQ:VYGR) to Post Q1 2024 Earnings of ($0.67) Per Share, Wedbush Forecasts

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) – Analysts at Wedbush issued their Q1 2024 earnings per share estimates for Voyager Therapeutics in a research report issued on Tuesday, May 9th. Wedbush analyst L. Chico forecasts that the company will post earnings per share of ($0.67) for the quarter. The consensus estimate for Voyager Therapeutics’ […] ....

Robin Swartz , Robertw Hesslein , Lazard Asset Management , Charles Schwab Investment Management Inc , Blackrock Inc , Securities Exchange Commission , Voyager Therapeutics Inc , Northern Trust Corp , Citigroup Inc , Tau Program , Voyager Therapeutics , Get Rating , Voyager Therapeutic , Truist Financial , Therapeutics Stock Down , Asset Management , Schwab Investment Management , Trust Corp , Exchange Commission , Guang Ping Gao , Voyager Therapeutics Daily , Nasdaq Vygr , Earnings Estimates ,

Voyager Therapeutics (NASDAQ:VYGR) Stock Crosses Below 50-Day Moving Average of $7.65

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $7.65 and traded as low as $7.61. Voyager Therapeutics shares last traded at $7.91, with a volume of 156,006 shares changing hands. Wall Street Analyst Weigh […] ....

United States , Robin Swartz , Neurocrine Biosciences Inc , Delphia United States Inc , Boothbay Fund Management , Voyager Therapeutics Inc , Securities Exchange Commission , Tau Program , Voyager Therapeutics Company Profile , Gamco Investors , Royal Bank , Voyager Therapeutics , Get Rating , Exchange Commission , Guang Ping Gao , Voyager Therapeutics Daily , Nasdaq Vygr ,

Voyager Therapeutics (NASDAQ:VYGR) Rating Lowered to Hold at StockNews.com

Voyager Therapeutics (NASDAQ:VYGR – Get Rating) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday. Separately, Oppenheimer initiated coverage on shares of Voyager Therapeutics in a research report on Thursday, March 9th. They issued an “outperform” rating and a $14.00 price target for […] ....

United States , Robin Swartz , Tau Program , Gamco Investors , Delphia United States Inc , Boothbay Fund Management , Voyager Therapeutics Company Profile , Neurocrine Biosciences Inc , Voyager Therapeutics Inc , Royal Bank , Voyager Therapeutics , Get Rating , Therapeutics Trading Down , Guang Ping Gao , Voyager Therapeutics Daily , Nasdaq Vygr , Stocknews Com ,

Insider Selling: Voyager Therapeutics, Inc. (NASDAQ:VYGR) COO Sells $28,355.04 in Stock

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) COO Robin Swartz sold 3,654 shares of the business’s stock in a transaction that occurred on Monday, March 20th. The shares were sold at an average price of $7.76, for a total value of $28,355.04. Following the completion of the sale, the chief operating officer now directly owns […] ....

United States , Robin Swartz , Man Group , Delphia United States Inc , Securities Exchange Commission , Voyager Therapeutics Inc , Gamco Investors , Boothbay Fund Management , Tau Program , Voyager Therapeutics , Get Rating , Exchange Commission , Therapeutics Trading Down , Street Group , Guang Ping Gao , Voyager Therapeutics Daily , Nasdaq Vygr , Insider Trading , Nsider Trades ,